Vaginal microbes are at the centre of a novel discovery that aims to investigate if these bacteria trap HIV or act as a courier service to deliver the virus to the host within the human body.

Griffith University is bidding a grateful farewell to community champion and Director of the Institute for Glycomics, Professor Mark von Itzstein AO. Professor von Itzstein will step down from his role as Director of the Institute for Glycomics, one of Australia’s flagship interdisciplinary translational biomedical research institutes, at the end of 2023. Griffith University’s Vice […]

From social justice leaders to health scientists, high achievers in aviation and tech entrepreneurs, Griffith University celebrates its bold and brilliant women this International Women’s Day.   This year’s theme from United Nations Women Australia, ‘Cracking the Code’, honours those accelerating gender equality through inclusive innovation, research discoveries and digital technologies.   Recipient of the Athena […]

Griffith University researchers are making inroads in ovarian cancer research looking at early detection signs and how the disease spreads through the body.

Griffith University researchers have unlocked one of the secrets as to why some forms of Strep A are associated with severe invasive infection.

Researchers awarded four NHMRC Ideas Grants worth more than $3.6 million.

Queensland will become a global mRNA vaccine hub with global healthcare company Sanofi partnering with Griffith University and other leading research institutions to establish a world-first research centre in south east Queensland.

Griffith University researchers will lead 17 new Discovery Projects across a broad field of knowledge after being awarded over $7.735 million from the Australian Research Council.

Griffith University, the Institute for Glycomics and Rotary are thrilled to announce The Honourable Anna Bligh AC will become the inaugural National Ambassador for its Malaria Vaccine Project.

A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.

Griffith named in nation-wide research rankings.

Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.

We are delighted to share some successful outcomes for NHMRC Investigator Fellowships announced on 12 October 2022 by the National Health and Medical Research Council (NHMRC).

Griffith University’s Institute for Glycomics is partnering with Sanctuary Cove Golf and Country Club for a third year to raise funds to aid vital breast cancer research.

A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.

Griffith University researchers have played a key role in investigating a new molecule that protects bacteria against viruses and is associated with bacterial infection of plants.

The ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and improve treatment options for women.

Griffith University has launched two cancer research centres backed by $4.6 million in funding from the Australian Cancer Research Foundation this month.